Stockscreener 앱 받기
111.24
2.35%
2.55
전일 마감가:
$108.69
열려 있는:
$109.25
하루 거래량:
2.25M
Relative Volume:
0.64
시가총액:
$20.26B
수익:
$381.03M
순이익/손실:
$-1.01B
주가수익비율:
-18.70
EPS:
-5.95
순현금흐름:
$-789.25M
1주 성능:
+9.33%
1개월 성능:
+13.74%
6개월 성능:
+37.32%
1년 성능:
+54.91%
1일 변동 폭
$108.00
$111.28
1주일 범위
$102.21
$111.28
52주 변동 폭
$60.40
$111.28
Insmed Inc Stock (INSM) Company Profile
명칭
Insmed Inc
전화
908-977-9900
주소
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
INSM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
111.24 | 20.65B | 381.03M | -1.01B | -789.25M | -5.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 118.67B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
571.54 | 59.23B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
419.56 | 52.67B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
690.32 | 41.24B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
304.30 | 32.36B | 3.81B | -644.79M | -669.77M | -6.24 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-13 | 개시 | Jefferies | Buy |
| 2025-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-23 | 개시 | Truist | Buy |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-07-26 | 개시 | Guggenheim | Buy |
| 2022-12-09 | 개시 | Mizuho | Buy |
| 2022-12-07 | 개시 | Barclays | Overweight |
| 2022-11-18 | 개시 | BofA Securities | Buy |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2021-12-06 | 개시 | JP Morgan | Overweight |
| 2021-10-19 | 재개 | Monness Crespi & Hardt | Buy |
| 2021-10-19 | 재개 | Morgan Stanley | Overweight |
| 2021-10-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-10-12 | 재개 | Stifel | Buy |
| 2019-09-03 | 개시 | Goldman | Buy |
| 2019-04-09 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-15 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-01-02 | 개시 | Canaccord Genuity | Buy |
| 2018-08-06 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | 개시 | Goldman | Neutral |
| 2018-04-23 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | 개시 | Morgan Stanley | Overweight |
| 2018-01-18 | 개시 | Credit Suisse | Neutral |
| 2017-09-05 | 재확인 | Evercore ISI | Outperform |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-07-11 | 개시 | Robert W. Baird | Outperform |
| 2016-03-15 | 개시 | Stifel | Buy |
| 2015-11-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2015-10-06 | 재확인 | H.C. Wainwright | Buy |
| 2015-06-09 | 개시 | Citigroup | Neutral |
| 2014-03-26 | 재확인 | HC Wainwright | Buy |
모두보기
Insmed Inc 주식(INSM)의 최신 뉴스
Insmed Surges 2 35 on Pipeline Breakthroughs and Capital Restructuring Despite Ranking 449th in Daily Liquidity - AInvest
October 17th Options Now Available For Insmed (INSM) - Nasdaq
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas - The Globe and Mail
Price Floor Holding on Insmed Incorporated — Rebound PossibleTop Performing Stock Insights Released Daily - metal.it
Should I hold or sell Insmed Incorporated stock in 2025Discover high-return stocks for your portfolio - Jammu Links News
How volatile is Insmed Incorporated stock compared to the marketUnlock powerful stock screening tools today - Jammu Links News
Is Insmed Incorporated stock overvalued or undervaluedFree Popular Stock Recommendations - Jammu Links News
What institutional investors are buying Insmed Incorporated stockExceptional financial outcomes - Jammu Links News
Insmed Incorporated Stock Analysis and ForecastInvest confidently with real-time market updates - Jammu Links News
How does Insmed Incorporated generate profit in a changing economyStay informed with expert market forecasts - Jammu Links News
How does Insmed Incorporated compare to its industry peersCapitalize on momentum-driven investment opportunities - Jammu Links News
What is Insmed Incorporated company’s growth strategyRemarkably fast returns - Jammu Links News
Published on: 2025-08-03 19:34:24 - Jammu Links News
Does Insmed Incorporated stock perform well during market downturnsDiscover breakthrough stocks before the crowd - Jammu Links News
What are analysts’ price targets for Insmed Incorporated in the next 12 monthsMaximize returns with strategic trading plans - Jammu Links News
Published on: 2025-08-03 14:14:55 - Jammu Links News
When is Insmed Incorporated stock expected to show significant growthMaximize returns with timely market signals - Jammu Links News
Visual trend scoring systems applied to Insmed IncorporatedConsistent Gain Investment Strategies Emerge - metal.it
Insmed’s Pipeline Growth With Brensocatib Approval And Phase 3 Trials - Yahoo Finance
Will Insmed (INSM) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Insmed Incorporated (INSM) Q2 Earnings Surge on Strong Drug Development Momentum. - AInvest
Strong Drug Development Momentum Lifted Insmed Incorporated (INSM) in Q2 - Yahoo Finance
Insmed stock hits 52-week high at 106.84 USD By Investing.com - Investing.com Canada
Insmed stock hits 52-week high at 106.84 USD - Investing.com
Published on: 2025-07-29 08:44:12 - metal.it
Screener Results Flag Insmed Incorporated as OversoldWeekly Top Gainers Forecast Watchlist Released - beatles.ru
Insmed Incorporated Breaks Below Key Support LevelSector Rotation Based Trading Opportunities Identified - metal.it
Multi Factor Analysis Ranks Insmed Incorporated as Strong BuySafe Entry Stock Watch Suggestions for Cautious Traders - metal.it
What makes Insmed Incorporated stock price move sharplyHigh Conviction Intraday Stock Signals Detected - metal.it
What are the latest earnings results for Insmed IncorporatedSwing Trade Insights With Proven Results - jammulinksnews.com
Synthetic rescue: Insmed explores a new frontier in genetic therapeutics - Yahoo Finance
Is it the right time to buy Insmed Incorporated stockGet real-time alerts on top-performing stocks - jammulinksnews.com
Why is Insmed Incorporated stock attracting strong analyst attentionCapitalize on market trends early - Jammu Links News
United Therapeutics Faces Key Moment With Tyvaso's Q3 Results - Finimize
Is Insmed Incorporated stock a growth or value playRobust investment performance - Jammu Links News
This Biotech Says It Has A 'Skeleton Key' For Disease - Investor's Business Daily
Insmed to Host Second-Quarter 2025 Financial Results Conference Call on Thursday, August 7, 2025 - Lelezard
Insmed’s Rare-Disease Pipeline Draws Investor Interest Ahead Of Key Decisions - Finimize
What drives Insmed Incorporated stock priceAccelerated wealth building - Autocar Professional
Is Insmed Incorporated a good long term investmentHigh-yield growth strategies - Autocar Professional
Insmed Inc (INSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
8.31%
자본화:
|
볼륨(24시간):